Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinogenesis × Immunohistochemistry × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 48 Head and Neck Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 19 Lung Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Colorectal Neoplasms 16 Rectal Neoplasms 14 Melanoma 14 Colonic Neoplasms 14 Pancreatic Neoplasms 11 Lymphoma, Follicular 10 Carcinoma, Ovarian Epithelial 10 Lymphoma 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Carcinoma, Renal Cell 8 Salivary Gland Neoplasms 7 Central Nervous System Neoplasms 7 Breast Neoplasms, Male 7 Uterine Cervical Neoplasms 6 Unspecified Adult Solid Tumor, Protocol Specific 6 Sarcoma 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, B-Cell, Marginal Zone 6 Liver Neoplasms 6 Kidney Neoplasms 6 Gliosarcoma 6 Glioblastoma 6 Fallopian Tube Neoplasms 6 Urinary Bladder Neoplasms 5

Interventions

Blood Specimen Collection 2 poly ICLC 1 Vinorelbine 1 Tissue Banks 1 Therapeutics 1 Reverse Transcriptase Polymerase Chain Reaction 1 Probiotics 1 Poly I-C 1 Pemetrexed 1 Paclitaxel 1 Monatide (IMS 3015) 1 Immunohistochemistry 1 Docetaxel 1 Cosmetics 1 Cisplatin 1 Carboplatin 1 Bronchoalveolar Lavage 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06778538 2025-01-16

HPGD-ccRCC

Lanzhou University Second Hospital

Carcinoma, Renal Cell, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡